Respiratory diseases

Advance your therapy to the patients who need it most with clinical research support from our therapeutically aligned, highly specialized experts. We have in-depth knowledge and extensive experience in supporting trials across a range of respiratory diseases, allowing us to deliver exceptional personalized experiences.

Exceptional knowledge, every step of the way

Our respiratory experience in both clinical practice and pharmaceutical research and development enables us to deliver exceptional personalized experiences and resolve your unique challenges across multiple respiratory indications.

The global respiratory drug market continues to grow as respiratory conditions such as asthma, idiopathic pulmonary fibrosis (IPF) and respiratory tract infections (RTI) continue to affect the global population. Particularly challenging, COPD is the third greatest cause of death globally, creating a huge need for innovation in this area.

Respiratory drug trials face unique challenges which can prove time consuming and expensive, partly because lung disease is complex and difficult to measure. Finding the right clinical trial subjects and managing large amounts of trial data also present challenges.

Our team has delivered and supported trials across innovative and generic products including drugs, medical devices and in vitro diagnostics for respiratory diseases.

Our services cover your entire product lifecycle including clinical development plan, pre-IND/IND, phase I-III and post-marketing Phase IV studies, as well as NDA submission and pharmacovigilance. We coordinate all aspects of your program through innovative monitoring and visual analytics to deliver the highest quality data you need to advance your respiratory therapy.

Your project will be designed and led by a team who understands the respiratory clinical settings and patient archetypes, connecting you with hospitals and outpatient settings to help you accelerate trial start-up and get the results you need.

Specialized clinical research solutions

Shared knowledge is power

We are fully invested in the outcomes of your trials, providing the resources and expertise when and how you need them and sharing therapeutic area expertise and knowledge to help you make the best decisions.

Gateway to the globe

Speak to a global expert

Ready for the next step in your respiratory drug development journey? Learn more about how our personalized solutions can help you enable better healthcare outcomes for those affected by respiratory conditions globally.

Schedule a 15 minute call
Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.



Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors

MORRISVILLE, N.C., November 9, 2022 – Caidya, the multi-therapeutic clinical ...



dMed | Clinipace announce corporate name change to Caidya

SHANGHAI and MORRISVILLE, N.C., October 3, 2022 – dMed | Clinipace, ...